<add><doc>
	<field name = "DATE">9-APR-1987 09:49:36.32</field>
	<field name = "PLACES">usa</field>
	<field name = "titulo">BIOTHERAPEUTICS BITX> REPORTS DRUG FINDINGS</field>
	<field name = "DATELINE">FRANKLIN, Tenn., April 9 -</field>
	<field name = "content">Biotherapeutics Inc said its
cooperative findings on interleukin-2, the anti-cancer drug,
were published today in the "New England Journal of Medicine".
    Biotherapeutics, along with the Biological Therapy
Institute and the National Cancer Institute, said the
publication focused on a reduction in toxicity through the use
of a constant infusion mode of intravenous administration
protocol.
 Reuter</field>
</doc></add>
